Creative Biolabs-Immuno-oncology

Anti-Gliadin (clone 1G0Z0Z2E-1GE0Z1G) SynExpress E1-Cy3-β-Sm Modified CD8+ T cells (CAT#: ITS-1224-CR508)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target Gliadin (clone 1G0Z0Z2E-1GE0Z1G). We employs the AAV (EF1α-Cy3-β-catenin-SmaI) vector components and the SynExpress system of the Exons Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
Gliadin
Clone
1G0Z0Z2E-1GE0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
β-catenin
Insertion Sites
SmaI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
AAV
Transformation Accuracy
0.95
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.